SCIENTIFIC-PRACTICAL JOURNAL

| укр | рус |

 

 


No3-4(5) 2022

Back to the issue


DOI 10.37219/2528-8253-2022-3-23

Pochuieva TV, Filatova GA
Peculiarities of bone tissue metabolism in patients with acute otitis media with impared carbonhydrate metabolism
Pochuiеva Tatiana V.
Department of Otorhinolaryngology and Pediatric Otolaryngology,Professor
Kharkiv Academy of Postgraduate Education
Email: pochuevatv@ukr.net
ORCID ID: https://orcid.org/0000-0002-4138-7091

Filatova Anna A.
Department of Otorhinolaryngology and Pediatric Otolaryngology
Kharkiv Academy of Postgraduate Education
Email : ane4kafilatova@ukr.net
ORCID ID: https://orcid.org/0000-0002-7480-754X

Abstract

Introductions: Relevance of the study is due to the unrecognized effect of carbohydrate metabolism disorders on bone tissue metabolism in patients with acute otitis media (AOM).
Aim: to determine the peculiarities of bone tissue metabolism in patients with AOM caused by disorders of carbohydrate metabolism.
Materials and methods: Our study included 73 patients aged 18 to 79 (29 males and 44 females) who were randomized into 4 groups according to the aim of the research:
Group 1 – 17 patients with AOM,
Group 2 – 15 patients with AOM combined with paranasal sinus pathology,
Group 3 – 20 patients with AOM on the background of type 2 diabetes mellitus,
Group 4 – 21 patients with AOM combined with transitory disorders of glucose metabolism.
On the basis of clinical examination all patients were tested for glycosylated hemoglobin (HbAlc), blood calcium level and parathormone as a marker of bone resorption and osteocalcin as a marker of bone remodeling.
Results of the study and discussion: The statistical evaluation of the indicators identified a reliable difference between groups 1-2 and groups 3-4, while between groups 1 and 2, 3 and 4 reliable difference in metabolic parameters of bone tissue has not been established. The level of glucosylated hemoglobin was significantly elevated even for transitory signs of carbohydrate metabolism disorders (5,17±0,17%, 4,95±0,17%, 9,8±0,46% and 7,78±0,19% in groups 1,2, 3 and 4 respectively).The value of parathormone was within the reference values, but it proved to be significantly (p˂0,001) higher in glucose metabolism disorders (56.8±3.02pg/ml and 52.56±2.7pg/ml in groups 3 and 4, respectively).The amount of osteocalcin and calcium tended to decrease in type 2 diabetes mellitus (group 3) and in transitory disorders (group 4), but without a significant difference (p˃0.05).
Correlation analysis revealed a strong correlation between glucose and glucosylated hemoglobin levels in patients in group 3 and the average strength in patients in group 4 (r=0.832 and r=0.44, respectively). The increase of parathormone level on the basis of carbohydrate metabolism disorders was due to the presence of correlation with the level of glucosylated haemoglobin in groups 3 and 4 (r=0.705 and r=0.81 respectively). Calcium correlations of r=-0.77 and r=-0.56 with parathormone level and r=-0.79 and r=-0.44 with glucosylated haemoglobin level were found in patients of groups 3 and 4 accordingly. In the absence of glucose metabolism disorders in groups 1 and 2, no significant correlations were found, except for physiologically determined correlations of parathormone and calcium levels in group 1 (r=-0.489).
Conclusions: Disorders of carbohydrate metabolism negatively affect metabolism of bone tissue due to activation of bone resorption processes. This is manifested by correlated with the level of glycosylated hemoglobin by an increase in the amount of parathormone with pathogenetic significance of both type 2 diabetes mellitus and transitory disorders of carbohydrate metabolism.In this category of patients, the level of parathormone and its dynamics, as well as the determination of glucosylated hemoglobin are informative even in transitory disorders of carbohydrate metabolism. 

Keywords

bone metabolism, carbohydrate metabolism disorders, acute otitis media, parathormone, glucosylated hemoglobin.


Reference

  1. Bezeha MI. [Improving the efficiency of treatment of patients with acute otitis media complicated mastoidit is using modified conservative and surgical techniques] [dissertation]. Kiev: State Institution «O. S. Kolomiychenko Institute of otolaryngology of National academy of medical sciences of Ukraine»; 2018. 186 p. Available from: http://www.iol.com.ua/article/bezega_dis.pdf. [In Ukrainian].
  2. Botella Martínez S, Varo Cenarruzabeitia N, Escalada San Martin J, Calleja Canelas A. The diabetic paradox: Bone mineral density and fracture in type 2 diabetes. Endocrinol Nutr. 2016;63(9):495-501. doi: 10.1016/j.endonu.2016.06.004.
  3. Chitadze K, Jorbenadze T, Adamia M. [Pathomorphological changes under latent mastoiditis]. Georgian Med News. 2017;(267):111-4. [Article in Russian].
  4. Compston J. Type 2 diabetes mellitus and bone. J Intern Med. 2018;283(2):140-153. doi: 10.1111/joim.12725. [Article in English].
  5. Furst JR, Bandeira LC, Fan WW, Agarwal S, Nishiyama KK, McMahon DJ, Dworakowski E, Jiang H, Silverberg SJ, Rubin MR. Advanced Glycation Endproducts and Bone Material Strength in Type 2 Diabetes. J Clin Endocrinol Metab. 2016;101(6):2502-10. doi:10.1210/jc.2016-1437.
  6. Golz A, Netzer A, Goldenberg D, Westerman ST, Westerman LM, Joachims HZ. The association between iron-deficiency anemia and recurrent acute otit is media. Am J Otolaryngol. 2001;22(6):391-4. doi:10.1053/ajot.2001.28075.
  7. Kanazawa I, Sugimoto T. Diabetes Mellitusinduced Bone Fragility. Intern Med. 2018;57(19): 2773-85. doi:10.2169/internalmedicine.0905-18.
  8. Kanazawa I. Interaction between bone and glucose metabolism [Review]. Endocr J. 2017;64(11): 1043-53. doi:10.1507/endocrj.EJ17-0323.
  9. Kenna MA. Otitis media and the new guidelines. J Otolaryngol. 2005;34 Suppl 1:S24-32.
  10. Khoruziy OI. [Pathomorphological and clinical and biochemical assessment of treatment tactics for acute otitis media with sensoneural hearing loss] [dissertation]. Thernopol: I. Horbachevsky Ternopil National Medical University; 2015. 143 p. Available from: http://www.iol.com.ua/article/khoruziy_dis.pdf. [In Ukrainian].
  11. Krivopalov AA, Fanta IV. [Acute otitis media: epidemiology, classification, etiology and treatment]. Medical Council. 2016;(4):53-5. https://doi.org/10.21518/2079-701X-2016-4-53-55. [Article in Russian].
  12. Laulajainen Hongisto A, Jero J, Markkola A, Saat R, Aarnisalo AA. Severe Acute Otitis Media and Acute Mastoiditis in Adults. J Int Adv Otol. 2016;12(3):224-30. doi:10.5152/iao.2016.2620.
  13. Lewiecki EM. Management of skeletal health in patients with asymptomatic primary hyperparathyroidism. J Clin Densitom. 2010;13(4):324-34. doi:10.1016/j.jocd.2010.06.004.
  14. Makras P, Anastasilakis AD. Bone disease in primary hyperparathyroidism. Metabolism. 2018;80: 57-65. doi: 10.1016/j.metabol.2017.10.003.
  15. Malovana IV. [Differentiated approaches to correction of metabolic disorders in patients with purulent otit is media] [dissertation]. Ternopil: Ternopil National Medical University; 2008. 168 p. [In Ukranian].
  16. Monasta L, Ronfani L, Marchetti F, Montico M, Vecchi Brumatti L, Bavcar A, Grasso D, Barbiero C, Tamburlini G. Burden of disease caused by otitis media: systematic review and global estimates. PLoS One. 2012;7(4):e36226. https://doi.org//10.1371/journal.pone.0036226.
  17. Murgasova L, Jurovcik M, Jesina P, Malinova V, Bloomfield M, Zeman J, Magner M. Otorhinolaryngological manifestations in 61 patients with mucopolysaccharidosis. Int J Pediatr Otorhinolaryngol. 2020;135:110137. doi:10.1016/j.ijporl. 2020.110137.
  18. Pochuieva TV, Filatova GA, Filatova IV, Iyevleva VI. [Pathogenetic significance of hyperglycemia in the format ion of the course peculiarities of acute otit is media and its complicat ions]. International Medical Journal. 2022;4:71-9. [Article in Ukrainian].
  19. Pochuieva TV, Filatova IV, Miroshnichenko OS, Filatova GA. Clinical portrait of a patient with type 2 diabetes mellitus as the basis for the specific course of acute otitis media. Otolaryngology. 2021; 4(6): 14-25. DOI 10.37219/2528-8253-2021-6-14. [Article in Ukrainian].
  20. Pochuiеva T, Filatova A, Filatova I. Features of the clinical course of acute otitis media in patients with impared carbonhydrate metabolism. EUREKA: Health Sciences. 2022;(1):17-29. doi: http://doi.org/10.21303/2504-5679.2022.002280.
  21. Rijk MH, Hullegie S, Schilder AGM, Kortekaas MF, Damoiseaux RAMJ, Verheij TJM, Venekamp RP. Incidence and management of acute otitis media in adults: a primary care-based cohort study. Fam Pract. 2021;38(4):448-53. doi: 10.1093/ fampra/cmaa150.
  22. Sanches CP, Vianna AGD, Barreto FC. The impact of type 2 diabetes on bone metabolism. Diabetol Metab Syndr. 2017;9:85. doi:10.1186/s13098-017-0278-1.
  23. Schilder AG, Marom T, Bhutta MF, Casselbrant ML, Coates H, Gisselsson-Solén M, Hall AJ, Marchisio P, Ruohola A, Venekamp RP, Mandel EM. Panel 7: Otitis Media: Treatment and Complications. Otolaryngol Head Neck Surg. 2017;156(4_suppl):S88-S105. doi: 10.1177/0194599816633697.
  24. Seidel DU, Bode S, Kostev K, Park JJ. Incidence of Inner Ear Disorders in Various Forms of Acute Otitis Media in ENT Practices in Germany. Ear Nose Throat J. 2021;100(3_suppl):325S-332S. doi: 10.1177/0145561320930568.
  25. Shirai N, Preciado D. Otitis media: what is new? Curr Opin Otolaryngol Head Neck Surg. 2019;27 (6):495-8.doi:10.1097/MOO.0000000000000591.
  26. Smith A, Gutteridge I, Elliott D, Cronin M. Acute otitis media associated bilateral sudden hearing loss: case report and literature review. J Laryngol Otol. 2017;131(S2):S57-S61. doi: 10.1017/ S0022215117000779.
  27. Tanninex E. [Peculiarities of the clinical course of acute mastoiditis]. Zhurnal ushnyh, nosovyh i gorlovyh boleznej. 2003;(2):86-8. [In Ukrainian]
  28. Vaidya V, Gangan N, Sheehan J. Impact of cardiovascular complications among patients with Type 2 diabetes mellitus: a systematic review. Expert Rev Pharmacoecon Outcomes Res. 2015;15(3): 487-97. doi:10.1586/14737167.2015.1024661.
  29. Wiertsema SP, Veenhoven RH, Sanders EA, Rijkers GT. Immunologic screening of children with recurrent otitis media. Curr Allergy Asthma Rep. 2005;5(4):302-7. doi:10.1007/s11882-005-0070-4.
  30. Wilmot EG, Davies MJ, Yates T, Benhalima K, Lawrence IG, Khunti K. Type 2 diabetes in younger adults: the emerging UK epidemic. Postgrad Med J. 2010;86(1022):711-8. doi: 10.1136/ pgmj.2010.100917.
  31. Yashan AI, Khoruzhy IV. [The influence of dead lymphocytes from middle ear secretion on the development of sensorineural hearing impairment associated with acute otitis media]. Vestn Otorinolaringol. 2015;(1):17-20. doi: 10.17116/otorino 201580117-20. [Article in Russian].
  32. Zhao C, Liu G, Zhang Y, Xu G, Yi X, Liang J, Yang Y, Liang J, Ma C, Ye Y, Yu M, Qu X. Association between serum levels of bone turnover markers and bone mineral density in men and women with type 2 diabetes mellitus. J Clin Lab Anal. 2020;34(4):e23112. doi: 10.1002/jcla. 23112.
  33. Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2): 88-98. doi:10.1038/nrendo.2017.151.
 

© 2019, Public Organization «Ukrainian Scientific Medical Society of Otorhinolaryngologists»